Showing results (231-240 of 1,098) with videos related to
Sort By:
Pageof 110
BMJ Open|May 16, 2023
Impact of polyethylene glycol loxenatide on cardiovascular outcomes in patients with type 2 diabetes: study protocol for a multicentre, randomised, double-blind, placebo-controlled trial (BALANCE-3)Yun Xie, Jian Kuang, Quanmin Li, et al.Experimental Diabetes Research|February 1, 2013
Impact of GLP-1 receptor agonists on major gastrointestinal disorders for type 2 diabetes mellitus: a mixed treatment comparison meta-analysisFeng Sun, Kai Yu, Zhirong Yang, et al.Plos One|September 10, 2013
Human gut microbiota changes reveal the progression of glucose intoleranceXiuying Zhang, Dongqian Shen, Zhiwei Fang, et al.Obesity (Silver Spring, Md.)|November 23, 2017
The Association Between the Dosage of SGLT2 Inhibitor and Weight Reduction in Type 2 Diabetes Patients: A Meta-AnalysisXiaoling Cai, Wenjia Yang, Xueying Gao, et al.BMJ (Clinical Research Ed.)|January 5, 2018
Incidence of type 1 diabetes in China, 2010-13: population based studyJianping Weng, Zhiguang Zhou, Lixin Guo, et al.Endocrine|May 31, 2022
Assessment of ovarian reserve in patients with type 1 diabetes: a systematic review and meta-analysisWenjia Yang, Chu Lin, Mengqian Zhang, et al.Expert Review of Clinical Pharmacology|July 15, 2022
The association between the use of sodium glucose cotransporter 2 inhibitor and the risk of diabetic retinopathy and other eye disorders: a systematic review and meta-analysisYunke Ma, Chu Lin, Xiaoling Cai, et al.Frontiers in Pharmacology|August 20, 2024
Retrospective analysis of the effect of SGLT-2 inhibitors on renal function in patients with type 2 diabetes in the real worldRongjing Song, Qiaoyu Hou, Xiuying Zhang, et al.Atherosclerosis|August 1, 2023
Anti-inflammatory therapies were associated with reduced risk of myocardial infarction in patients with established cardiovascular disease or high cardiovascular risks: A systematic review and meta-analysis of randomized controlled trialsZonglin Li, Chu Lin, Xiaoling Cai, et al.Journal of Diabetes|July 8, 2017
Prevalence of and risk factors for diabetic ketosis in Chinese diabetic patients with random blood glucose levels >13.9 mmol/L: Results from the CHina study in prEvalence of diabetiC Ketosis (CHECK) studyLeili Gao, Yufeng Li, Dadong Fei, et al.Pageof 110